Accelera

As a full-service CRO, Accelera offers complete IND/CTA-enabling programs including GLP-compliant, repeat-dose tox in Non-Human Primates (NHPs) and reproductive toxicity testing in rats and rabbits

Accelera is approaching you with an exceptional opportunity to secure a slot for NHPs and Dogs and Rats toxicology and DART studies in 2025/2026

Why Accelera:

• 50 + NHPs projects run in the last decade with multiple modalities like small molecules, mono-clonal anti-bodies, ADC, mRNA, Cell therapy.
• Fully GLP and AAALAC accredited
• More than 30 years of experience in providing a wide range of integrated services able to support all phases of the development including the global registration of a new drug candidate

Please contact our BD expert for info:

Francesco Sola

francesco.sola@accelera.org